Try the modernized beta website. Learn more about the modernization effort.
Working… Menu

The Role of Bexarotene in Inducing Susceptibility to Chemotherapy in Metastatic TNBC

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details. Identifier: NCT04664829
Recruitment Status : Recruiting
First Posted : December 11, 2020
Last Update Posted : December 11, 2020
National Medical Research Council (NMRC), Singapore
Information provided by (Responsible Party):
National Cancer Centre, Singapore

No Study Results Posted on for this Study
Recruitment Status : Recruiting
Estimated Primary Completion Date : June 30, 2023
Estimated Study Completion Date : June 30, 2023